Autopsy report · NCT05298891

Hypoproteic Diet in Acromegaly

“ethical issue”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 12 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Na

Sponsor

Azienda Ospedaliero Universitaria Maggiore della Carita

Sponsor type

University, hospital or other

Conditions

Acromegaly

Interventions

Usual clinical practice + hypoproteic diet

Participants

12 (planned, not actual)

Sites

1

Countries

Italy

Trials that died the same way

• Effect of Intra-articular Injection on Temporomandibular Joint Dysfunction
  “ethical issues” (94% match in meaning)
• The Effect of ACT and Float REST on Burnout Syndrome.
  “Ethics Committee concerns.” (65% match in meaning)
• Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
  “Study was not given ethical approval- a alternative protocol required” (58% match in meaning)
• Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)
  “medical/ethical reasons” (58% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.